PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 146 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $9,000 | -25.0% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,000 | +9.1% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,000 | -21.4% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +27.3% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | +10.0% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | -28.6% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | -22.2% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $18,000 | +5.9% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $17,000 | +21.4% | 2,272 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $14,000 | -91.7% | 2,272 | -90.0% | 0.00% | -90.0% |
| Q3 2017 | $168,000 | +46.1% | 22,806 | +35.0% | 0.01% | +42.9% |
| Q2 2017 | $115,000 | +310.7% | 16,897 | +473.8% | 0.01% | +250.0% |
| Q1 2017 | $28,000 | – | 2,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |